The system, developed by researchers at the University of Waterloo and DarwinAI, an alumni-founded startup company, uses artificial intelligence (AI) to predict the necessity of ICU admission based on more than 200 clinical data points, including vital signs, blood test results and medical history.
The study, which was conducted by researchers from Tulane, Central South University in China, the University of Oklahoma Health Sciences Center, Temple University, and Florida State University, was designed to test whether AI could be a tool to help pathologists keep pace with the rising demand for their services.
Nowadays, Artificial Intelligence (AI) is deployed more and more to predict life-threatening disease. But there remains a big challenge in getting the Machine Learning (ML) algorithms precise enough.